180 Life Sciences Corp. recently approved the grant of stock options totaling 965,000 shares of common stock to various members of the company. The breakdown includes 410,000 shares to CEO Blair Jordan, 25,000 shares to Chief Accounting Officer Eric R. Van Lent, 255,000 shares to Lead Director Ryan Smith, 165,000 shares to Director Stephen H. Shoemaker, and 110,000 shares to Director Dr. Lawrence Steinman. These grants were made as consideration for services rendered and to be rendered to the company. The document does not specify the price of these transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 180 Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-056232), on June 20, 2025, and is solely responsible for the information contained therein.